[
    [
        {
            "time": "",
            "original_text": "健帆生物2019年一季报点评:业绩超市场预期,高增长持续",
            "features": {
                "keywords": [
                    "健帆生物",
                    "2019年一季报",
                    "业绩",
                    "超市场预期",
                    "高增长"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "健帆生物2019年一季报点评:业绩超市场预期,高增长持续",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "【医药丨周小刚】健帆生物(300529)：扣非利润增速超50%，业绩大超预期",
            "features": {
                "keywords": [
                    "健帆生物",
                    "扣非利润",
                    "增速超50%",
                    "业绩大超预期"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【医药丨周小刚】健帆生物(300529)：扣非利润增速超50%，业绩大超预期",
                "Correlation": 10,
                "Sentiment": 10,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "【医药-马帅】健帆生物：Q1业绩超市场预期，静待RCT试验结果发布",
            "features": {
                "keywords": [
                    "健帆生物",
                    "Q1业绩",
                    "超市场预期",
                    "RCT试验结果"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【医药-马帅】健帆生物：Q1业绩超市场预期，静待RCT试验结果发布",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]